摘要
84例中度哮喘病人分成2组。色甘酸钠组(男性23例,女性20例,年龄26±s8a)吸入色甘酸钠混悬气雾剂10.5mg,tid。茶碱缓释胶囊组(男性22例,女性19例,年龄27±8a)口服0.25g。bid。2组均连续观察3mo。结果:色甘酸钠在减轻病人慢性症状、改善肺功能和降低气道高反应性等方面优于茶碱缓释胶囊,(P<0.01)。而后药仅可缓解近期症状。
Eighty-four patients with moderate asthma were randomly divided into two groups.The Disodium cromoglicate group(M 23,F 20;age 26±s8a)inhaled cromoglycate sodium aerosol 10.5 mg,tid,for 3 mo.Theophylline slow-release capsule group(M22,F 19;age27±8a)received 0.25g,po, bid, for3 mo.Resultes showed that,in contrast to theophylline slow-release capsule group,inhaled cromoglycate aerosol significantly improved clinical chronic symptoms,lung function,and bronchial hyperreactivity(all P<0.01).Theophylline slow-release capsule only improved short-term symptoms.
出处
《新药与临床》
CSCD
北大核心
1995年第3期154-157,共4页
关键词
哮喘
色甘酸钠
茶碱
气雾剂
迟效制剂
asthma
disodium cromoglicate
theophylline
aerosols
delayed-action preparations
respiratory function tests